Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

Christian M. Zwaan, Gertjan J.L. Kaspers, Rob Pieters, Karel Hählen, Gritta E. Janka-Schaub, Christina H. Van Zantwijk, Dieuwke R. Huismans, Esther De Vries, Marianne G. Rots, Godefridus J. Peters, Gerrit Jansen, Ursula Creutzig, Anjo J.P. Veerman

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

140 Citaten (Scopus)

Samenvatting

Children with Down syndrome (DS) have an increased risk for leukemia.The prognosis for DS acute myeloid leukemia (AML) is better than for non-DS AML, but the clinical outcome of DS acute lymphoblastic leukemia (ALL) is equal to that of non-DS ALL. Differences in prognosis may reflect differences in cellular drug resistance. In vitro drug resistance profiles were successfully investigated on leukemic cells from 13 patients with DS AML and 9 patients with DS ALL and were compared with reference data from 151 non-DS AML and 430 non-DS B-cell precursor (BCP) ALL. DS AML cells were significantly more sensitive to cytarabine (median, 12-fold), theanthracyclines (2-7-fold), mitoxantrone (9-fold), amsacrine (16-fold),etoposide (20-fold), 6-thioguanine (3-fold), busulfan (5-fold), vincristine (23-fold), and prednisolone (more than 1.1-fold), than non-DS AML cells. Compared with DS ALL, DS AML cells were significantly more sensitive to cytarabine only (21-fold). After short-term exposure to methotrexate, DS AML cells were 21-fold more resistant than non-DS AML cells, but no difference was observed after continuous exposure. DS ALL cells and non-DS BCP-ALL cells were equally sensitive to all drugs, including methotrexate. Normal peripheral blood mono-nuclear cells from DS and non-DS children without leukemia showed highly resistant drug profiles. It was concluded that the better prognosis of DS AML might, at least partially, be explained by a specific, relatively sensitive drug-resistance profile, reflecting the unique biology of this disease.

Originele taal-2Engels
Pagina's (van-tot)245-251
Aantal pagina's7
TijdschriftBlood
Volume99
Nummer van het tijdschrift1
DOI's
StatusGepubliceerd - 1 jan. 2002
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome'. Samen vormen ze een unieke vingerafdruk.

Citeer dit